Compounds > pyrazolanthrone
Page last updated: 2024-08-18

pyrazolanthrone and Kidney Neoplasms

pyrazolanthrone has been researched along with Kidney Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, M; Xie, H; Xu, M1
Chen, YC; Chien, CC; Chiu, WT; Wu, WS1
Du, ZX; Gao, YY; Guan, Y; Liu, BQ; Meng, X; Wang, HQ; Zhang, HY1
An, J; Guo, Y; Huang, J; Liu, H; Magyar, CE; Rettig, MB; Srivatsan, ES; Veena, MS1

Other Studies

4 other study(ies) available for pyrazolanthrone and Kidney Neoplasms

ArticleYear
Histone deacetylase inhibitors induce human renal cell carcinoma cell apoptosis through p-JNK activation.
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2013, Volume: 33, Issue:10

    Topics: Anthracenes; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Renal Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; MAP Kinase Signaling System; Panobinostat; Phosphorylation; Proto-Oncogene Proteins c-bcl-2

2013
Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells.
    PloS one, 2016, Volume: 11, Issue:8

    Topics: Adenine; Animals; Anthracenes; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; eIF-2 Kinase; Gene Expression Regulation; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; Male; Membrane Potential, Mitochondrial; Mice, Nude; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays

2016
Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression.
    British journal of pharmacology, 2009, Volume: 158, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Anthracenes; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; Leupeptins; Mitogen-Activated Protein Kinase 8; p38 Mitogen-Activated Protein Kinases; Proteasome Inhibitors; Pyridines; Signal Transduction

2009
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma.
    Cancer research, 2013, Feb-15, Volume: 73, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Animals; Anthracenes; B-Cell CLL-Lymphoma 10 Protein; Blotting, Western; Carcinoma, Renal Cell; CARD Signaling Adaptor Proteins; Cell Line, Tumor; Enzyme Activation; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; MAP Kinase Kinase 4; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Phosphorylation; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; RNA Interference; TNF Receptor-Associated Factor 6; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays; Zearalenone

2013